Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-08-09
2011-08-09
Crane, Lawrence E (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S042000, C536S004100, C536S018700
Reexamination Certificate
active
07994140
ABSTRACT:
The present invention relates to a method of identifying a candidate therapeutic agent. The method comprises contacting a G-Protein Coupled Receptor (GPCR) with a compound of General Formula (I), or a pharmaceutically acceptable salt thereofdetermining whether the compound inhibits or effects signal transduction activity of the GPCR, wherein a compound that inhibits or effects the activity of the GPCR is a candidate therapeutic agent.
REFERENCES:
patent: 4376207 (1983-03-01), Uskokovic et al.
patent: 4495346 (1985-01-01), Anderson et al.
patent: 4548923 (1985-10-01), Hartmann et al.
patent: 5552534 (1996-09-01), Hirschmann et al.
patent: 5811512 (1998-09-01), Hirschmann et al.
patent: 6017926 (2000-01-01), Askew et al.
patent: 6030942 (2000-02-01), Cooperman et al.
patent: 6184366 (2001-02-01), Christ et al.
patent: 6417172 (2002-07-01), Rossignol et al.
patent: 6756489 (2004-06-01), Schmidt et al.
patent: 7138531 (2006-11-01), Sas et al.
patent: 7232900 (2007-06-01), Johnson et al.
patent: 7417129 (2008-08-01), West et al.
patent: 2003/0232766 (2003-12-01), West et al.
patent: 2008/0176936 (2008-07-01), Meutermans et al.
patent: 102 59 844 (2004-07-01), None
patent: WO 93/17032 (1993-09-01), None
patent: WO 95/11686 (1995-05-01), None
patent: WO 97/28172 (1997-08-01), None
patent: 99/00406 (1999-01-01), None
patent: WO 99/07718 (1999-02-01), None
patent: WO 00/42057 (2000-07-01), None
patent: WO 01/36433 (2001-05-01), None
patent: 01/98270 (2001-12-01), None
patent: WO 02/32915 (2002-04-01), None
patent: WO 02/085867 (2002-10-01), None
patent: WO 03/082846 (2003-10-01), None
patent: WO 2004/014929 (2004-02-01), None
patent: WO 2004/032940 (2004-04-01), None
(R) Kroeze et al., “G-Protein-Coupled Receptors [GPCRs] at a Glance,” Journal of Cell Science, 116, 4867-4869 (2003).
S. Budavari et al., “The Merck Index”, Thirteenth Edition, pp. 793-794, monograph 4471, 2001.
Knapp et al, “Amino Alcohol and Amino Sugar Synthesis by Benzoylcarbamate Cyclization”, J. Org. Chem. 55:5700-5710 (1990).
Ichikawa et al, “A new synthetic method for the preparation of amino sugars through an ally cyanate-to-isocyanate rearrangement”, J. Chem. Soc. Perkin Trans. 1:1449-1455 (1997).
Bosserhoff, Anja-Katrin, “Integrins as targets in therapy”, Expert Opin. Ther. Patents 16)7):963-975 (2006).
Arnaout et al, “Coming to grips with integrin binding to ligands: Opinion”, Current Opinion in Cell Biology 14:641-651 (2002).
Boer et al, “Design, Synthesis, and Biological Evaluation of α4β1Integrin Antagonists Based on β-D-Mannose as Rigid Scaffold”, Angew. Chem. Int. Ed. 40(20):3870-3873 (2001).
Clark and Brugge, “Integrins and Signal Transduction Pathways: The Road Taken”, Science 268:233-238 (1995).
Hirschmann et al, “Modulation of Receptor and Receptor Subtype Affinities Using Diastereomeric and Enantiomeric Monosaccharide Scaffolds as a Means to Structural and Biological Diversity. A New Route to Ether Synthesis”, Journal of Medicinal Chemistry 41(9):1382-1391 (1998).
Lehmann et al, “Role of αvβ5 and αvβ6 Integrin Glycosylation in the Adhesion of a Colonic Adenocarcinoma Cell Line (HT29-D4)”, Journal of Cellular Biochemistry 61:266-277 (1996).
Longhi et al, “Involvement of Membrane Carbohydrates of HeLa Cells in theE. ColiHB101 (pRI203) Invasive Pathway”, Microbiologica 15:107-116 (1992).
Moitessier et al, “Design, Synthesis and Preliminary Biological Evaluation of a Focused Combinatorial Library of Stereodiverse Carbohydrate-Scaffold-Based Peptidomimetics”, Bioorganic & Medicinal Chemistry 9:511-523 (2001).
Nicolaou et al, “Design, Synthesis and Biological Evaluation of Carbohydrate-Based Mimetics”, Tetrahedron 53(26):8751-8778 (1997).
Stern et al, “Human Monocyte-Derived Macrophage Phagocytosis of Senescent Eosinophils Undergoing Apoptosis”, American Journal of Pathology 149(3):911-921 (1996).
Du et al, “The recognition of three different epitopes for the H-type 2 human blood group determinant by lectins of Ulex europaeus, Galactia tenuiflora and Psophocarpus tetragonolobus (Winged Bean”, Glycoconjugate Journal 11:443-461 (1994).
Advisory Action dated Feb. 10, 2011 issued in connection with U.S. Appl. No. 10/524,048.
Office Action dated Nov. 2, 2010 issued in connection with U.S. Appl. No. 10/524,048.
Hirschmann et al, “Nonpeptidal Peptidomimetrics with a β-D-Glucose Scaffolding. A Partial Somatostatin Agoinst Bearing a Close Structural Relationship to a Potent, Selective Substance P Antagonist”, J. Am. Chem. Soc. 114:9217-9218 (1992).
Gruner et al, “Carbohydrate-Based Mimetics in Drug Design: Sugar Amino Acids and Carbohydrate Scaffolds”, Chem. Rev. 102:491-514 (2002).
Le et al, “Molecular diversity through sugar scaffolds”, DDT 8(15):701-709 (2003).
Ye and Wong, “Anomeric Reactivity-Based One-Pot Oligosaccharide Synthesis: A Rapid Route to Oligosaccharide Libraries”, J. Org. Chem. 65:2410-2431 (2000).
Christ, W. J., “New monosaccharide derivatives, useful as intermediates for substituted liposaccharides for treating endotoxemia such as sepsis, septicemia and toxic shock”, Derwent Abstract Accession No. 2002-371191/40, Mar. 7, 2002.
Maletic et al, “Preparation of Potential Inhibitors of the Mur-Pathway Enzymes on Solid Support Using an Acetal Linker”, Bioorganic & Medicinal Chemistry Letters 13:1125-1128 (2003).
Fukase et al, “New Efficient Route for Synthesis of Lipid A by using Affinity Separation”, Synlett 11:1693-1698 (2001).
Nakayama et al, “Novel peptidomimetics of the antifungal cyclic peptide Rhodopeptin: design of mimetics utilizing scaffolding methodology”, Organic Letters 3(22):3447-3450 (2001).
Yoshizaki et al, “First total synthesis of the Re-type lipopolysaccharide”, Angew. Chem., Int. Ed. 40(8):1475-1480 (2001).
Hanessian et al, “Formation of p-alkoxybenzylidene acetals on solid support and generation of functional diversity with carbohydrate scaffolds”, Synlett 1:102-104 (1999).
Carey and Sundberg, “Advanced Organic Chemistry, Part B: Reactions and Synthesis”, Copyright 2001, Kulwer Academic/Plenum Publishers, pp. 831-835.
Greene et al, “Protective Groups in Organic Synthesis”, published 1999 by John Wiley and Sons, Inc, pp. 494-653.
International Search Report dated Sep. 9, 2003 issued in connection with PCT/AU03/01008.
Abbenante Giovanni
Halliday Judy
Le Thanh Glang
Meutermans Wim
Tometzki Gerald
Alchemia Limited
Crane Lawrence E
Nixon & Vanderhye
LandOfFree
Classes of compounds that interact with GPCRs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Classes of compounds that interact with GPCRs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Classes of compounds that interact with GPCRs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2751140